Publication:
Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients

Simple item page
dc.contributor.authorYILMAZ, ABDULKERİM
dc.contributor.authorALAGÖZLÜ, HAKAN
dc.contributor.authorÖZDEMİR, ÖZTÜRK
dc.contributor.authorArici, Sema
dc.contributor.institutionauthorARICI, DILEK SEMA
dc.date.accessioned2020-10-29T17:15:56Z
dc.date.available2020-10-29T17:15:56Z
dc.date.issued2014-07-01T00:00:00Z
dc.description.abstractBackground: The specific antiviral T cells provide CC chemokine receptor 5 (CCR5) for the immune response during the hepatitis C virus (HCV) infection. Heterogenous and/or homozygous 32 base pair deletion in CCR5 gene (CCR5 432 bpdel) leads to reduced protein expression.
dc.identifier.citationYILMAZ A., ALAGÖZLÜ H., ÖZDEMİR Ö., Arici S., -Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients-, HEPATITIS MONTHLY, cilt.14, 2014
dc.identifier.doi10.5812/hepatmon.11283
dc.identifier.scopus84904291154
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25630
dc.identifier.wosWOS:000344637600001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleEffects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients
dc.typeArticle
dspace.entity.typePublication
local.avesis.id391b7b4f-293b-4e6c-b515-8c0f23509a14
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication39582b2a-f3bf-47fe-9483-87678e56820e
relation.isAuthorOfPublication.latestForDiscovery39582b2a-f3bf-47fe-9483-87678e56820e
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Silinecekler